HIV Mutation Detail Information

> L90M Search Result

Mutation Information

Mutation Site	L90M
Mutation Type	Amino acid level
Gene/Protein/Region Type	PR
Relevant Drug	bictegravir (BIC);emtricitabine (FTC);tenofovir alafenamide (TAF);dolutegravir (DTG)

Literature Information

PubMed PMID	32701823
Disease	HIV infection/AIDS
Published Year	2020
Journal	Journal of acquired immune deficiency syndromes (1999)
Title	Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-existing NRTI Resistance.
Author	Acosta RK,Willkom M,Andreatta K,Liu H,Martin R,Parvangada A,Martin H,Collins S,White KL
Evidence	Frequent substitutions were M46I/L, Q58E, or L90M in PR No documented resistance to INSTIs or confirmed.

Contents
Description

Mutation Information Note

Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)

Literature Information Note

Evidence: sentence contains this mutation information in the citation